H

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566

Watchlist Manager
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Watchlist
Price: 28.36 CNY -5.5% Market Closed
Market Cap: 26B CNY
Have any thoughts about
Hubei Jumpcan Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 46.9 CNY. Compared to the current market price of 28.36 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
46.9 CNY
Undervaluation 40%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hubei Jumpcan Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Hubei Jumpcan Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Hubei Jumpcan Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Hubei Jumpcan Pharmaceutical Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Hubei Jumpcan Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Hubei Jumpcan Pharmaceutical Co Ltd.

What unique competitive advantages
does Hubei Jumpcan Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Hubei Jumpcan Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide P/S
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide P/E
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide P/OCF
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide P/FCFE
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide P/B
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/S
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/GP
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/EBIT
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/OCF
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/FCFF
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide EV/IC
for Hubei Jumpcan Pharmaceutical Co Ltd.

Show me price targets
for Hubei Jumpcan Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Hubei Jumpcan Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Hubei Jumpcan Pharmaceutical Co Ltd?

What are the Net Income projections
for Hubei Jumpcan Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Hubei Jumpcan Pharmaceutical Co Ltd?

What are the EPS projections
for Hubei Jumpcan Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Hubei Jumpcan Pharmaceutical Co Ltd?

What are the EBIT projections
for Hubei Jumpcan Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Hubei Jumpcan Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Hubei Jumpcan Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hubei Jumpcan Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hubei Jumpcan Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hubei Jumpcan Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Hubei Jumpcan Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hubei Jumpcan Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Hubei Jumpcan Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide ROE
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide ROA
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide ROIC
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide ROCE
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Gross Margin
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Operating Margin
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Net Margin
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide FCF Margin
for Hubei Jumpcan Pharmaceutical Co Ltd.

Show all solvency ratios
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide D/E Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide D/A Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Quick Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Current Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

Provide Cash Ratio
for Hubei Jumpcan Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Hubei Jumpcan Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Hubei Jumpcan Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Hubei Jumpcan Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hubei Jumpcan Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hubei Jumpcan Pharmaceutical Co Ltd

Current Assets 14.2B
Cash & Short-Term Investments 11.6B
Receivables 1.8B
Other Current Assets 735.3m
Non-Current Assets 3.8B
Long-Term Investments 432.3m
PP&E 2.9B
Intangibles 476.4m
Other Non-Current Assets 32.7m
Current Liabilities 4.3B
Accounts Payable 1.5B
Accrued Liabilities 155.1m
Short-Term Debt 1.8B
Other Current Liabilities 909.9m
Non-Current Liabilities 216.1m
Long-Term Debt 1.2m
Other Non-Current Liabilities 214.9m
Efficiency

Earnings Waterfall
Hubei Jumpcan Pharmaceutical Co Ltd

Revenue
9.1B CNY
Cost of Revenue
-1.9B CNY
Gross Profit
7.2B CNY
Operating Expenses
-4.4B CNY
Operating Income
2.8B CNY
Other Expenses
60.2m CNY
Net Income
2.8B CNY

Free Cash Flow Analysis
Hubei Jumpcan Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROIC
76/100
Profitability
Score

Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Long-Term Solvency
Low D/E
85/100
Solvency
Score

Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hubei Jumpcan Pharmaceutical Co Ltd

Wall Street analysts forecast Hubei Jumpcan Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.

Lowest
Price Target
52.88 CNY
86% Upside
Average
Price Target
53.41 CNY
88% Upside
Highest
Price Target
54.98 CNY
94% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hubei Jumpcan Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hubei Jumpcan Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Hubei Jumpcan Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

26.1B CNY

Dividend Yield

0%

Description

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs. The company is headquartered in Taizhou, Jiangsu and currently employs 6,632 full-time employees. The company went IPO on 2001-08-22. The firm's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The firm mainly distributes its products within domestic markets.

Contact

JIANGSU
Taizhou
Baotawan, Daqing West Road, Taixing City
+8652389719161
www.jumpcan.com

IPO

2001-08-22

Employees

6 632

Officers

Vice Chairman & GM
Mr. Fei Cao
Vice Chairman
Mr. Qu Rong Huang
Deputy GM & Financial Director
Mr. Hong Quan Yan
Director of Human Resources
Mr. Wen Zheng Shi
Deputy GM, Board Secretary & Director
Mr. Wei Cao
Deputy General Manager
Mr. Qian Zhao

See Also

Discover More
What is the Intrinsic Value of one Hubei Jumpcan Pharmaceutical Co Ltd stock?

The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 46.9 CNY.

Is Hubei Jumpcan Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 28.36 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 40%.

Back to Top